Semaglutide Shows Benefits for PAD Across T2D Subgroups ...Middle East

News by : (Medscape) -
A post-hoc analysis of STRIDE confirms the benefit of GLP-1 RA in patients with peripheral arterial disease and type 2 diabetes, but more research is needed in those without diabetes. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Semaglutide Shows Benefits for PAD Across T2D Subgroups )

Also on site :

Most Viewed News
جديد الاخبار